AbbVie Inc.
ABBV
$214.50
$2.201.04%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.50% | 8.57% | 7.40% | 6.05% | 5.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.50% | 8.57% | 7.40% | 6.05% | 5.45% |
| Cost of Revenue | 5.68% | 4.00% | 2.22% | -0.23% | -1.12% |
| Gross Profit | 11.06% | 10.49% | 9.62% | 8.82% | 8.39% |
| SG&A Expenses | -2.37% | -3.23% | -3.27% | 7.06% | 9.39% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -242.86% | -242.86% | -118.34% | -118.34% | -- |
| Total Operating Expenses | 4.27% | 2.91% | 1.93% | 4.94% | 6.00% |
| Operating Income | 20.85% | 21.20% | 19.82% | 8.45% | 4.26% |
| Income Before Tax | 64.96% | 77.53% | -76.93% | -57.12% | -51.90% |
| Income Tax Expenses | 501.72% | 514.74% | -135.61% | -143.18% | -138.07% |
| Earnings from Continuing Operations | -13.37% | -1.24% | -53.34% | -29.51% | -30.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.00% | 12.50% | 36.36% | 27.27% | 27.27% |
| Net Income | -13.35% | -1.22% | -53.38% | -29.52% | -30.00% |
| EBIT | 20.85% | 21.20% | 19.82% | 8.45% | 4.26% |
| EBITDA | 13.07% | 13.35% | 12.86% | 4.73% | 1.71% |
| EPS Basic | -13.63% | -1.34% | -53.76% | -29.71% | -30.18% |
| Normalized Basic EPS | 21.70% | 20.86% | 17.69% | 5.46% | 1.74% |
| EPS Diluted | -13.75% | -1.59% | -54.01% | -29.95% | -30.25% |
| Normalized Diluted EPS | 21.69% | 20.85% | 17.68% | 5.47% | 1.77% |
| Average Basic Shares Outstanding | 0.10% | 0.06% | -0.06% | -0.03% | -0.01% |
| Average Diluted Shares Outstanding | 0.10% | 0.06% | -0.06% | -0.04% | -0.04% |
| Dividend Per Share | 5.64% | 5.72% | 5.81% | 5.55% | 5.28% |
| Payout Ratio | 0.22% | 0.07% | 1.26% | 0.49% | 0.50% |